Corvus Pharmaceuticals In... (CRVS)
NASDAQ: CRVS
· Real-Time Price · USD
5.42
0.57 (11.75%)
At close: Aug 15, 2025, 3:59 PM
5.44
0.46%
After-hours: Aug 15, 2025, 06:30 PM EDT
11.75% (1D)
| Bid | 5.4 |
| Market Cap | 403.49M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -41.4M |
| EPS (ttm) | -1.1 |
| PE Ratio (ttm) | -4.92 |
| Forward PE | -6.58 |
| Analyst | Buy |
| Ask | 5.45 |
| Volume | 666,313 |
| Avg. Volume (20D) | 760,212 |
| Open | 4.96 |
| Previous Close | 4.85 |
| Day's Range | 4.92 - 5.49 |
| 52-Week Range | 2.54 - 10.00 |
| Beta | 0.41 |
About CRVS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CRVS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CRVS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+32.24%
Corvus Pharmaceuticals shares are trading higher a...
Unlock content with
Pro Subscription
3 months ago
+4.69%
Corvus Pharmaceuticals shares are trading higher after it reported Q1 EPS. Company also reported data from its Cohorts 1-3 of Placebo-Controlled phase 1 clinical trial
